The Latin America, Middle East and Africa Topical Scar Treatment Market would witness market growth of 11.6% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $641.3 million by 2030. The Argentina market is showcasing a CAGR of 12.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.2% during (2023 - 2030).
The trend toward personalized skincare has influenced the market as well. Companies have been exploring formulations tailored to individual skin types and scar conditions, offering more personalized solutions. Topical scar treatments incorporate advanced active ingredients such as peptides, hyaluronic acid, silicone, and other compounds known for their skin-repairing and regenerative properties.
There is a growing emphasis on preventing scarring and intervening early in the healing process. This has led to the development of products designed for use immediately after injury or surgery to minimize the appearance of scars. Consumer awareness about the importance of scar management has been on the rise. Companies are investing in educational campaigns to inform consumers about the benefits of using these and the importance of consistent application.
As per the International Trade Administration, the United Arab Emirates leads the Gulf Cooperation Council in eCommerce sales, which surged by 53% in 2020 to a record $3.9 billion, or 10% of overall retail sales. The Dubai Chamber of Commerce and Industry signifies that eCommerce will develop $8 billion in sales by 2025 as the UAE region has nearly 100% internet and mobile phone penetration. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $641.3 million by 2030. The Argentina market is showcasing a CAGR of 12.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.2% during (2023 - 2030).
The trend toward personalized skincare has influenced the market as well. Companies have been exploring formulations tailored to individual skin types and scar conditions, offering more personalized solutions. Topical scar treatments incorporate advanced active ingredients such as peptides, hyaluronic acid, silicone, and other compounds known for their skin-repairing and regenerative properties.
There is a growing emphasis on preventing scarring and intervening early in the healing process. This has led to the development of products designed for use immediately after injury or surgery to minimize the appearance of scars. Consumer awareness about the importance of scar management has been on the rise. Companies are investing in educational campaigns to inform consumers about the benefits of using these and the importance of consistent application.
As per the International Trade Administration, the United Arab Emirates leads the Gulf Cooperation Council in eCommerce sales, which surged by 53% in 2020 to a record $3.9 billion, or 10% of overall retail sales. The Dubai Chamber of Commerce and Industry signifies that eCommerce will develop $8 billion in sales by 2025 as the UAE region has nearly 100% internet and mobile phone penetration. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Market Report Segmentation
By End-use- Hospitals
- Clinics
- Homecare
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
- Creams
- Gels
- Silicon Sheets
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Topical Scar Treatment Market by End-use
Chapter 5. LAMEA Topical Scar Treatment Market by Scar Type
Chapter 6. LAMEA Topical Scar Treatment Market by Product
Chapter 7. LAMEA Topical Scar Treatment Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
Methodology
LOADING...
